Cancers Upcoming Events Announce Your Event Here
11–13 October 2018 Melbourne International Joint Breast Congress - ASBD, 4th CoBrCa & BreastSurgANZ
11–12 October 2018 3rd Annual Biomarkers & Precision Medicine USA Congress
San Diego, USA
The 3rd Annual Biomarkers & Precision Medicine USA Congress is part of Oxford Global’s R&D US Series that features 3 outstanding programmes: our long-running 5th Annual Drug Discovery and Chemistry USA Congress, the 3rd Annual Biomarker & Precision Medicine USA Congress, and fast-emerging Advances in Immuno-Oncology USA Congress.
This event will host over 300 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
Over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers
4 Interactive Streams:
- Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases
- Personalised Medicine, Companion Diagnostics & Patient Testing. Biomarker Assay Validation and Patient Stratification
- Innovations in Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies
- Biomarker in Clinical Development & Clinical Trials. Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing
Free Pre-Congress Live Webinars 2018
Moving Diagnostic Biomarkers from Bench into the Clinic
Hosted by James Snider, CSO and President, Critical Diagnostics & Elizabeth Somers, Director Diagnostics, Morphotek
Register today, for free: https://bit.ly/2HOCyR7
Moving Biomarkers from Bench into the Clinic
Hosted by Xuemei Zhao, Senior Principal Scientist, Merck & Co., Inc & Qing Kang, Senior Scientist, Translational Medicine at Syros Pharmaceuticals
Register today, for free: https://bit.ly/2Kw62VC
Driving Precision Medicine and Advancing Big Data in Drug Development
Hosted by Stefan Scherer, Vice President, Global Head Correlative Science, Novartis
Register today, for free: https://bit.ly/2I3sGGq
11–12 October 2018 Advances in Immuno-Oncology USA Congress
San Diego, USA
Due to the success of the UK Advances in Immuno-Oncology event, Oxford Global are expanding this event to the USA. The USA Congress is the first of its kind and will feature over 20 presentations from leading heads of the Pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate.
Topic discussion ranges across a variety of therapeutic strategies, from CAR T cell therapies to microbiome in Immuno-Oncology and from assays and modelling in Immuno-Oncology to NK cell-based therapeutics.
Further talks look at approaches to clinical trial design and development and Translational Immuno-Oncology. To enhance the interactivity of the program, we have also introduced discussion opportunities through panels, roundtables and workshops on hot topics in this field.
Key speakers include Vice Presidents, Directors and Executives from leading pharmaceutical industries such as Pfizer and Atreca. The two day congress offers the opportunity to have scientific and business discussions, ensuring valuable networking and interactive sessions.
The conference will bring together over 100 senior industry experts and key opinion leaders in Immuno-Oncology.
Free Pre-Congress Live Webinar
The Role For TNFR2 In The Tumor Microenvironment
Hosted by Russell LaMontagne, Chief Executive Officer, Boston Immune Technologies and Therapeutics Inc
- The role TNFR2 tregs
- TNFR2 Oncogene
- Novel TNFR2 antibodies
Why should you attend this webinar?
- Get an in-depth overview of the RWE landscape in Europe
- Hear key updates from IMI EMIF
- Discuss collaboration in this growing area
Register for free today
11–12 October 2018 5th Annual Drug Discovery USA Congress
San Diego, USA
Join Oxford Global’s 5th Annual Drug Discovery USA Congress taking place on the 11-12 October 2018 in San Diego. Across the two days, over 40 expert speakers will provide you with insights into the latest technological innovations and strategic approaches in drug discovery and drug chemistry.
View Agenda here.
The American biopharmaceutical research sector has been a world leader in the development of new medicines over the past 30 years and it continues to drive biopharmaceutical innovation. Our conference delivers an extensive look across the development process: from drug discovery innovation and strategies to computational chemistry and informatics for drug design.
The conference will feature over 40 presentations from leading heads of the pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate. Topic discussion ranges across the latest validation and optimisation strategies in neuroscience, cardiology and oncology. Further talks look at approaches to phenotypic and genomic drug discovery design, as well as novel approaches to drug design: AI-based design, DNA Encoded Libraries and protein-protein interactions.
Include 4 Streams:
- Day 1 Stream 1: Drug Discovery Innovation and Strategies
- Day 2 Stream 1: Phenotypic and Genomic Drug Discovery
- Day 1 Stream 2: Computational Chemistry and Informatics for Drug Discovery
- Day 2 Stream 2:
- Part 1: Novel Approaches to Drug Design
- Part 2: DNA Encoded Libraries